A rare case report on 90 day glaucoma due to branched retinal vein occlusion
DOI:
https://doi.org/10.18203/2320-6012.ijrms20213105Keywords:
Neovascular Glaucoma, BRVO, Iris Neovascularisation, Bevacizumab, Pan-Retinal Photocoagulation, CyclocryoablationyAbstract
A 19 year old female, presented to the ophthalmology OPD with pain and redness in her left eye since 30 days. Upon examination, there was no perception of light in left eye, both the pupils were mid-dilated and non-reactive to light stimulation. The left eye intra-ocular pressure (ATn) was 60 mm of Hg. On slit lamp examination, 3600 iris neovascularisation, ciliary congestion and corneal oedema were noted. Indirect gonioscopy revealed grade I angle closure in the left eye. Fundus examination of the affected eye revealed pale optic disc, CDR of 0.9:1, multiple dot and blot hemorrhages, suggestive of supero-temporal BRVO (branched retinal vein occlusion). Fundus fluorescein angiography revealed blocked fluorescence and leakage from neovascularization in the left eye. Conservative management with anti-glaucoma drugs failed to lower the IOP. Subsequently, pan-retinal photocoagulation (PRP) with intravitreal anti-VEGF (vascular endothelial growth factor) in the left eye followed by cyclo-cryoablation helped her symptoms to subside.
References
Rodrigues GB. Neovascular glaucoma: a review. Int J Retin Vitr. 2016;2:26.
Cãlugãru D, Cãlugãru M. Neovascular glaucoma-etipathogeny and diagnosis. Oftalmologia. 2012;56(2):3-14.
Albert DM, Jakobiec FA. Neovascular Glaucoma. In: Albert DM, Jakobiec FA, eds. Princiffes and practice of ophthalmology. 3rd ed. Philadelphia: WB Saunders Publishers; 1999.
Pedroso L, Junior EDSC, PAranhos A, Junior JAP, Mello PAA. The real cost of glaucoma treatment for an outpatient. Arq Bras Oftalmol. 1999;62(6):677-82.
Chen KH, Wu CC, Roy S, Lee SM, Liu JH. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci. 1999;40(11):2627-32.
Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma etiologic considerations. Ophthalmol. 1984;91(4):315-20.
Chan CK, Ip MS, Vanveldhuisen PC, et al. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. Ophthalmology. 2011;118(7):1364-72.
Madsen PH. Haemorrhagic glaucoma. Comparative study in diabetic and non-diabetic patients. Br J Ophthalmol. 1971;55(7):444-50.
Ohrt V. The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol (Copenh). 1971;49(2):301-7.
Browning DJ, Scott AQ, Peterson CB, Warnock J, Zhang Z. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology. 1998;105(5):776-84.
Havens SJ, Gulati V. Neovascular glaucoma. Retinal Pharmacotherapeutics. Basel: Karger Publishers; 2016: 196-204.
Shiba T, Takahashi M, Hori Y, Saishin Y, Sato Y, Maeno T. Relationship between sleep-disordered breathing and iris and/or angle neovascularization in proliferative diabetic retinopathy cases. Am J Ophthalmol. 2011;151(4):604-9.
Klein BE, Meuer SM, Knudtson MD, Klein R. The relationship of optic disk cupping to retinal vein occlusion: Beaver dam eye study. Am J Ophthalmol. 2006;141(5):859-62.
Ogino K, Tsujikawa A, Murakami T, Muraoka Y, Kurashige Y, Yoshimura N. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion. Clin Ophthalmol. 2011;5:1031-6.
Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol. 2011;5:281-6.
Mocanu C, Barascu D, Marinescu F. Neovascular glaucoma-Retrospective study. Ophthalmologica. 2005;49(4):58-65.
